AstraZeneca diabetes drug cuts heart risks in major study

AstraZeneca said on Monday its diabetes drug Farxiga met a key goal in a major clinical study designed to show the heart-protecting benefits of the medicine.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news